The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase 3 study of ivonescimab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of metastatic non–small cell lung cancer: HARMONi-3.
 
Jianjun Zhang
Honoraria - BeiGene; CancerNet; Geneplus; Geneplus; Hengrui Medicine; Innovent Biologics; innovent biologics; Innovent Biologics; Origimed; Roche; Roche China; Sino-USA Biomedical Platform; Suzhou Medical Association; Takeda; Varian Medical Systems; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; Capital Medical University; Geneplus; Hunan Cancer Hospital; Johnson & Johnson/Janssen; Novartis
Research Funding - Helius; Merck; Novartis; Summit Therapeutics
Travel, Accommodations, Expenses - innovent biologics; Zhejiang Cancer Hospital
 
Jun Cai
No Relationships to Disclose
 
Hui Wang
No Relationships to Disclose
 
Yan Yu
No Relationships to Disclose
 
Joaquim Bosch-Barrera
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche; Sanofi/Regeneron
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Takeda
 
Reyes Bernabé
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; PharmaMar; Roche; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; PharmaMar; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Janssen; Roche
 
Zoran Andric
No Relationships to Disclose
 
Firas Badin
Speakers' Bureau - Bristol-Myers Squibb/Pfizer; GE Healthcare; Jazz Pharmaceuticals; Lilly; Merck; Merck Serono; Regeneron
 
Yusuke Okuma
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca; Chugai Pharma; Eisai; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Summit Therapeutics (Inst)
 
Paul Paik
Consulting or Advisory Role - EMD Serono; Janssen; Summit Therapeutics
Research Funding - Bicara Therapeutics (Inst); EMD Serono (Inst); Novartis (Inst); Summit Pharmaceuticals (Inst)
 
Jarushka Naidoo
Honoraria - Abbvie/Genentech; Amgen; Arcus Biosciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Daiichi Sankyo/Lilly; Elevation Oncology; Gilead Sciences; Kaleido Biosciences; Merck; Mirati Therapeutics; NGM Biopharmaceuticals; Pfizer; Regeneron; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Arcus Biosciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Elevation Oncology; Gilead Sciences; Kaleido Biosciences; Merck; Merck KGaA; Mirati Therapeutics; NGM Biopharmaceuticals; Pfizer; Regeneron; Roche/Genentech; Takeda; Zymeworks
Research Funding - Amgen (Inst); AstraZeneca (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Pfizer
 
Haralabos Kalofonos
Consulting or Advisory Role - Amgen; Genesis Pharmaceuticals; GlaxoSmithKline; Leo Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche; Sanofi
Research Funding - Amgen (Inst); Genesis Pharmaceuticals (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Bo Wang
Stock and Other Ownership Interests - Roche/Genentech (I)
Consulting or Advisory Role - AstraZeneca; BeiGene; EMD Serono
Speakers' Bureau - EMD Serono
 
Robert Jotte
Leadership - Sarah Cannon Research Institute
Consulting or Advisory Role - AstraZeneca
 
Nathan Pennell
Consulting or Advisory Role - Anheart Therapeutics; bristol-myers sqibb; ConcertAI; Daiichi Sankyo; Genentech; Iovance Biotherapeutics; Janssen Oncology; Lilly; ResistanceBio; Takeda; Vial
Research Funding - Advenchen Laboratories (Inst); Anheart Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); InhibRx (Inst); Loxo (Inst); Merck (Inst); Mirati Therapeutics (Inst); Navire (Inst); Puma Biotechnology (Inst); Seattle Genetics/Astellas (Inst); Summit pharmaceuticals (Inst)
 
Jonathan Riess
Consulting or Advisory Role - Amgen; Bicycle Therapeutics; Bristol-Myers Squibb/Celgene; Catalyst Clinical Research; Daiichi Sankyo; Genentech; GlaxoSmithKline; Janssen Oncology; Merck; Merus NV; Oncohost; Pfizer; Regeneron; Replimune
Research Funding - ArriVent Biopharma (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); IO Biotech (Inst); Kinnate Biopharma (Inst); Merck (Inst); Novartis (Inst); Nuvalent, Inc. (Inst); Pfizer; Revolution Medicines (Inst); Summit pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; IO Biotech
 
Deborah Doroshow
Honoraria - MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Atheneum; Boehringer Ingelheim; Dedham Group; G1 Therapeutics; MJH Life Sciences; Sanofi; Sonata Therapeutics; Summit Therapeutics; Takeda
Travel, Accommodations, Expenses - Boehringer Ingelheim; MJH Life Sciences
Other Relationship - Bristol Myers Squibb Foundation; Conquer Cancer Foundation
 
Makoto Nishio
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo/UCB Japan; Eisai; Eisai; Janssen; Lilly; Merck; MSD; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
 
Jorge Alatorre-Alexander
Consulting or Advisory Role - Amgen; AstraZeneca; Janssen Oncology; Roche/Genentech
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb (Mexico); MSD; Roche/Genentech; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; Roche
 
Shun Lu
Leadership - Innovent BIOLOGICS, INC; Shanghai Fosun; Simcere Zaiming
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; InventisBio Co. Ltd; Menarini; Pfizer; Roche; Simcere; Yuhan; Zai Lab
Speakers' Bureau - AstraZeneca; Hansoh Pharma; Hengrui Therapeutics; Roche
Research Funding - AstraZeneca (Inst); BeiGene (Inst); BMS (Inst); Hansoh (Inst); Hengrui Therapeutics (Inst); Hutchison MediPharma (Inst); Lilly Suzhou Pharmaceutical Co. (Inst); Roche (Inst)